MSD has fleshed out the results of phase 3 trials of its cholesterol-lowering, oral PCSK9 inhibitor, enlicitide decanoate, showing its efficacy was comparable to that of injectable alternatives. The ...
TrumpRx is set to launch soon. President Donald Trump has been pressuring drug companies to lower prices. Americans currently pay about three times more for prescription medicine than patients in ...
TrumpRx is a government-run direct-to-consumer drug sale website. TrumpRx will launch in January 2026 A new government-run discount medicine website is set to launch this month. It's called TrumpRx: A ...
Amgen's acquisition of Dark Blue Therapeutics adds a small molecule targeting MLLT1/3 proteins in AML, enhancing its oncology portfolio. Amgen is committed to reducing drug costs, expanding its ...
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today announced the launch of RxSmartSaver powered by GoodRx at Giant Eagle ...
US names HIV, arthritis drugs for next Medicare price talks The U.S. government on Tuesday named the 15 new drugs targeted for Medicare price negotiations for 2028, including Gilead Sciences' HIV drug ...
Novo's Wegovy pill makes encouraging start in weight-loss race vs Lilly Novo Nordisk's Wegovy weight-loss pill has made an encouraging start after its launch this month, analysts said on Friday citing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results